CRISPR gene therapy Casgevy can nearly eliminate sickle cell crises, but difficult stem‑cell collection is delaying access ...
GA, UNITED STATES, February 4, 2026 / EINPresswire.com / — Researchers have developed a new biomimetic nanocomposite (mPDA-Cas9) for treating triple-negative breast cancer ( TNBC) by combining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results